CINCINNATI and SEOUL, South Korea, Jan. 31,
2023 /PRNewswire/ -- Meridian Bioscience, Inc.
(NASDAQ: VIVO), a leading global provider of diagnostic testing
solutions and life science raw materials, and SD Biosensor, Inc.
("SDB") (KOSE: A137310) and SJL Partners LLC ("SJL") (collectively,
the "Consortium"), announced today that they have completed the
transaction to acquire Meridian.
Under the terms of the merger, Meridian shareholders have the
right to receive $34.00 per share in
cash. Meridian stock will no longer be traded on the NASDAQ Global
Select Market. Meridian will continue to operate as an independent
entity, under new ownership, headquartered in Cincinnati, Ohio.
About SD Biosensor, Inc.
SD Biosensor, Inc., with its
slogan 'Beginning of all things that protect lives,' is a global
in-vitro diagnostics company that contributes to improving
everyone's quality of life by diagnosing diseases quickly and
accurately. SD Biosensor is a Total Solution Provider in the IVD
industry that develops and researches innovative diagnostic
platforms. For further information, refer to the official website
at https://www.sdbiosensor.com/.
About SJL Partners
SJL is a Korea-based private
equity investment manager uniquely focused on cross-border
partnership investments with market-leading strategic companies to
support their inorganic growth in international markets. SJL's
portfolio includes investments into Momentive Performance
Materials, a U.S.-based global leader in specialty silicones and
silicone derivatives, Momentive Technologies, a leader in fused
quartz and ceramic solutions, and Nexeon, a U.K.-based technology
leader in anode materials for rechargeable batteries. Additional
information is available at www.sjlpartners.com.
About Meridian Bioscience, Inc.
Meridian is a fully
integrated life science company that develops, manufactures,
markets, and distributes a broad range of innovative diagnostic
products. We are dedicated to developing and delivering better
solutions that give answers with speed, accuracy, and simplicity
that are redefining the possibilities of life from discovery to
diagnosis. Through discovery and development, we provide critical
life science raw materials used in immunological and molecular
tests for human, animal, plant, and environmental applications.
Through diagnosis, we provide diagnostic solutions in areas
including gastrointestinal and upper respiratory infections and
blood lead level testing. We build relationships and provide
solutions to hospitals, reference laboratories, research centers,
veterinary testing centers, physician offices, diagnostics
manufacturers, and biotech companies in more than 70 countries
around the world. Meridian's website address is
www.meridianbioscience.com.
Contact:
Charlie Wood
Vice President – Investor Relations
Meridian Bioscience, Inc.
Phone: +1 513.271.3700
Email: mbi@meridianbioscience.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/sd-biosensor-and-sjl-partners-complete-transaction-to-acquire-meridian-bioscience-301735165.html
SOURCE Meridian Bioscience, Inc.